title: Looking back, to the future of circulating tumor cells.
abstract: Detection and analysis of circulating tumor cells (CTCs) from patients with metastatic malignancies have become active areas of research in recent years. CTC enumeration has already proven useful in establishing prognosis for patients with metastatic breast, colon, and prostate cancer. More recently, studies are going beyond enumeration, exploring the CTCs as a means to better understand the mechanisms of tumorigenesis, invasion, and metastasis and the value of CTC characterization for prognosis and tailoring of treatment. Analysis of CTC subpopulations, for example, is highlighting the importance of the epithelial to mesenchymal transition (EMT), a process which may be crucial for allowing tumors to invade into and grow at sites distant from the original tumor site. Similarly, the detection of CTCs expressing markers of stemness may also have important implications for treatment resistance. Genomic analysis of CTC and CTC subpopulations may allow for selection of novel therapeutic targets to combat treatment resistance. CTCs become a particularly valuable biospecimen resource when tissue biopsies are unavailable or not feasible and liquid biopsies allow for serial monitoring. Lastly, cultures of patient-derived CTCs may allow for an evaluation of therapeutic strategies performed ex vivo and in real time. This review article will focus on these developments, starting with the CTC pathogenesis, going on to discuss the different platforms available for CTC isolation and their use to date in these arenas, then will explore multiple topics including the existing data concerning CTC subpopulations and their clinical relevance, genomic characterization, and lastly, avenues for future research.
authors.affiliation: Division of Hematology & Medical Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, United States. Electronic address: terence.friedlander@ucsf.edu.
authors.forename: Terence W
authors.initials: TW
authors.lastname: Friedlander
authors.affiliation: Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, United States.
authors.forename: Gayatri
authors.initials: G
authors.lastname: Premasekharan
authors.affiliation: Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, United States.
authors.forename: Pamela L
authors.initials: PL
authors.lastname: Paris
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor; D002452:Cell Count; D018929:Cell Culture Techniques; D002469:Cell Separation; D002986:Clinical Trials as Topic; D058750:Epithelial-Mesenchymal Transition; D006801:Humans; D009360:Neoplastic Cells, Circulating
chemical_list: D014408:Biomarkers, Tumor
keywords: CellSearch; Circulating tumor cells; EpCAM; Epithelial to mesenchymal transition; Stem-cells